Summus Global

Overview
News
Telehealth?
Product stageSegments
Go-to-Market
?
Specialized Telemedicine
?

Summus Global is a virtual specialist platform that connects patients with medical specialists from around the world. Founded in 2015, the company utilizes proprietary technology to create a new healthcare model, where members can quickly connect with leading doctors for personalized, condition-specific support across the continuum of care. Summus' platform covers a wide range of specialties, from allergies and weight management to complex conditions like cancer and ALS. 

Summus uses algorithms to match patients with appropriate specialists based on factors such as the physician's training, areas of expertise, research, clinical outcomes, procedure volume, and patient preferences. The platform integrates various techniques, including video conferencing, electronic health records, and imaging systems, to facilitate comprehensive virtual consultations.

In February 2022, Summus launched Summus Wellbeing, a program grounded in Lifestyle Medicine that enables employers to help employees and family members maintain healthier lives through personalized virtual journeys with health experts. The program focuses on six pillars of Lifestyle Medicine: nutrition, sleep, exercise, stress management, risky behavior reduction, and social connectedness.

Key customers and partnerships

As of August 2024, the company provided care in over 120 specialties and subspecialties through its network of over 5,100 specialists. The company offers its platform on a B2B2C basis, working with enterprise clients, health plans, healthcare providers, and medical groups to provide its services.

In May 2022, Summus announced a collaboration with Boston Children's Hospital to support innovative ways to scale specialist expertise and reach more patients and families worldwide. As part of this collaboration, Summus supports Boston Children's Online Second Opinion Program, helping more families access the hospital's expertise. Since its inception, the program has supported thousands of families across the globe, with 68% of consultations resulting in some change in recommended treatment.

HQ location:
32 E 43rd St New York NY USA
Founded year:
2015
Employees:
51-100
IPO status:
Private
Total funding:
USD 56.8 mn
Last Funding:
USD 19.5 mn (Series Unknown; Sep 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.